Home infusion therapy is safe and enhances compliance in patients with mucopolysaccharidoses

Barbara K Burton*, Chani Wiesman, Andrea Paras, Katherine H Kim, Rachel Katz

*Corresponding author for this work

Research output: Contribution to journalArticle

18 Scopus citations

Abstract

The transition to home infusion therapy is described in 11 patients with mucopolysaccharide (MPS) disorders initially treated with enzyme replacement therapy (ERT) in an out-patient infusion center. Home therapy was well tolerated with no infusion-related reactions (IRR) occurring in 671 patient-weeks of treatment. In addition, compliance with the weekly treatment regimen was improved in patients on home therapy.

Original languageEnglish (US)
Pages (from-to)234-236
Number of pages3
JournalMolecular Genetics and Metabolism
Volume97
Issue number3
DOIs
StatePublished - Jul 1 2009

Keywords

  • Enzyme replacement therapy
  • Home infusion
  • Hunter syndrome
  • Mucopolysaccharidoses

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Home infusion therapy is safe and enhances compliance in patients with mucopolysaccharidoses'. Together they form a unique fingerprint.

  • Cite this